Low molecular weight heparin or unfractionated heparin in the treatment of patients with uncomplicated deep vein thrombosis

Journal of Accident and Emergency Medicine

Volumn 17, Issue 6, 2000, Pages 402-403

  Lane, B ^a   Harrison, M ^a   Mackway Jones, K ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

CLINICAL TRIAL; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; LEG PAIN; SHORT SURVEY; ARTICLE; EMERGENCY HEALTH SERVICE; EVIDENCE BASED MEDICINE; MEDLINE; VEIN THROMBOSIS;

ANTICOAGULANTS; EMERGENCY SERVICE, HOSPITAL; EVIDENCE-BASED MEDICINE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MEDLINE; VENOUS THROMBOSIS;

EID: 0034328170     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.17.6.402     Document Type: Short Survey

References (4)

1. Subcutaneous low weight molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis
2. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home
3. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal vein thrombosis
4. Comparison of low molecular weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital and subcutaneous heparin administered at home for deep vein thrombosis